MUSCARINIC ACETYLCHOLINE-RECEPTOR SUBTYPES IN SMOOTH-MUSCLE

被引:211
作者
EGLEN, RM [1 ]
REDDY, H [1 ]
WATSON, N [1 ]
CHALLISS, RAJ [1 ]
机构
[1] UNIV LEICESTER,DEPT CELL PHYSIOL & PHARMACOL,LEICESTER LE1 9HN,LEICS,ENGLAND
关键词
D O I
10.1016/0165-6147(94)90047-7
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Muscarinic acetylcholine M(2) and M(3) receptor subtypes are coexpressed in many types of smooth muscle including gastrointestinal smooth muscle, urinary bladder and vascular and airway tissue. Activation of M(3) receptors, via the G protein G(q), results in increased polyphosphoinositide hydrolysis, release of Ca2+ ions from the sarcoplasmic reticulum and consequently causes contraction. Quantitation of the relative expression of M(2) and M(3) receptors has shown that the proportion of M(2) receptors often predominates over the M(3) receptor population by 4:1 or more. Although it is established that M(2) receptors preferentially link, via a pertussis-toxin-sensitive G protein G(i), to inhibition of adenylate cyclase activity, relatively little is known concerning the physiological role of the M(2) receptor population. In this review, Richard Eglen and colleagues discuss recent data concerning the possible role(s) of muscarinic receptor subtypes in smooth muscle and appraise the pharmacological methods for dissecting the function of muscarinic receptor subtypes in tissues coexpressing multiple receptors.
引用
收藏
页码:114 / 119
页数:6
相关论文
共 62 条
[1]  
ARJONA NC, 1993, AM REV RESPIR DIS, V147, pA177
[2]   COMPARISON OF AFFINITY CONSTANTS FOR MUSCARINE-SENSITIVE ACETYLCHOLINE RECEPTORS IN GUINEA-PIG ATRIAL PACEMAKER CELLS AT 29 DEGREESC AND IN ILEUM AT 29 DEGREESC AND 37 DEGREESC [J].
BARLOW, RB ;
BERRY, KJ ;
GLENTON, PAM ;
NIKOLAOU, NM ;
SOH, KS .
BRITISH JOURNAL OF PHARMACOLOGY, 1976, 58 (04) :613-620
[3]   CHARACTERIZATION OF MUSCARINIC RECEPTOR SUBTYPES INHIBITING CA2+ CURRENT AND M-CURRENT IN RAT SYMPATHETIC NEURONS [J].
BERNHEIM, L ;
MATHIE, A ;
HILLE, B .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1992, 89 (20) :9544-9548
[4]   A MUSCARINIC RECEPTOR DIFFERENT FROM THE M1, M2, M3 AND M4 SUBTYPES MEDIATES THE CONTRACTION OF THE RABBIT IRIS SPHINCTER [J].
BOGNAR, IT ;
ALTES, U ;
BEINHAUER, C ;
KESSLER, I ;
FUDER, H .
NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 1992, 345 (06) :611-618
[5]   ANTAGONIST DISCRIMINATION BETWEEN GANGLIONIC AND ILEAL MUSCARINIC RECEPTORS [J].
BROWN, DA ;
FORWARD, A ;
MARSH, S .
BRITISH JOURNAL OF PHARMACOLOGY, 1980, 71 (02) :362-364
[6]  
CANDELL LM, 1990, MOL PHARMACOL, V38, P689
[7]   MUSCARINIC RECEPTORS - CHARACTERIZATION, COUPLING AND FUNCTION [J].
CAULFIELD, MP .
PHARMACOLOGY & THERAPEUTICS, 1993, 58 (03) :319-379
[8]   PHARMACOLOGY OF THE PUTATIVE M4-MUSCARINIC RECEPTOR MEDIATING CA-CURRENT INHIBITION IN NEUROBLASTOMA X GLIOMA HYBRID (NG-108-15) CELLS [J].
CAULFIELD, MP ;
BROWN, DA .
BRITISH JOURNAL OF PHARMACOLOGY, 1991, 104 (01) :39-44
[9]   2ND MESSENGER AND IONIC MODULATION OF AGONIST-STIMULATED PHOSPHOINOSITIDE TURNOVER IN AIRWAY SMOOTH-MUSCLE [J].
CHALLISS, RAJ ;
ADAMS, D ;
MISTRY, R ;
BOYLE, JP .
BIOCHEMICAL SOCIETY TRANSACTIONS, 1993, 21 (04) :1138-1145
[10]   PHOSPHOINOSITIDE METABOLISM IN AIRWAY SMOOTH-MUSCLE [J].
CHILVERS, ER ;
NAHORSKI, SR .
AMERICAN REVIEW OF RESPIRATORY DISEASE, 1990, 141 (03) :S137-S140